Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

David Pearson1, Maxime Garnier1, Alexandre Luneau2

  • 1a Pharmacokinetic Sciences , Novartis Institutes for BioMedical Research , Novartis Pharma AG , Basel , Switzerland.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|September 15, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

Science translational medicine·2026
Same author

En route to renal transplantation: peritoneal dialysis immediately after laparoscopic Roux-en-Y bariatric surgery may be safe.

BMJ case reports·2026
Same author

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

The New England journal of medicine·2026
Same author

Computational Chemistry Approach in the Assessment of Potential Acyl Glucuronide-Mediated Toxicity.

Current drug metabolism·2026
Same author

22-year experience with bariatric revision surgery; What have we learned?

American journal of surgery·2025
Same author

Beyond Liquid Chromatography: Cyclic Ion Mobility Spectrometry for Phosphorothioate Diastereomer Separation in siRNA.

Analytical chemistry·2025
Same journal

Berberine Hydrochloride Induces Apoptosis in Triple-Negative Breast Cancer Cells Through Modulation of the sirtuin/p65 Signaling Axis.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same journal

Computational analysis of dual targeting of β<sub>1</sub>-adrenergic and AT<sub>1</sub> receptors by bisoprolol fumarate and candesartan cilexetil for hypertensive modulation.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same journal

Total saponins from ginseng stems and leaves antagonise acute lead-cadmium co-exposure-induced oxidative liver damage in mice via the Keap1/Nrf2 signalling pathway.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same journal

Intestinal deglycosylation activates saikosaponins as potent, selective UGT2B7/2B15 inhibitors: structural basis and implications for herb-drug interactions.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same journal

Tetrahydrouridine pre-treatment increases tissue exposure of <sup>14</sup>C-decitabine in mice.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same journal

Modulatory role of fucoidan against monosodium glutamate-induced reproductive and hepatorenal toxicity in adult male rats.

Xenobiotica; the fate of foreign compounds in biological systems·2026
See all related articles

Leniolisib, a PI3K delta inhibitor, is primarily eliminated via metabolism, with drug-related material excreted in urine and feces. This study demonstrates effective mass balance determination without radiolabeling.

Area of Science:

  • Pharmacology
  • Drug Metabolism and Pharmacokinetics
  • Clinical Chemistry

Background:

  • Leniolisib is an investigational oral phosphatidylinositol-3-kinase (PI3K) delta inhibitor.
  • It is being developed for inflammatory and autoimmune diseases.

Purpose of the Study:

  • To investigate the absorption, metabolism, and excretion (ADME) of leniolisib.
  • To assess leniolisib's pharmacokinetic profile in healthy subjects following a single oral dose.

Main Methods:

  • A first-in-human clinical study involving a single 400 mg oral dose of leniolisib.
  • Quantification of parent drug and metabolites in plasma, urine, and feces using 19F-NMR and liquid chromatography.
  • Structure determination of metabolites via liquid chromatography coupled to tandem mass spectrometry.
Keywords:
CDZ173Leniolisibfluorine NMRhuman ADMEmetabolite identificationphosphatidylinositol-3-kinase (PI3K) delta inhibitor

Related Experiment Videos

Main Results:

  • Drug-related material was predominantly excreted as oxidative metabolites in urine and feces, indicating metabolism as the primary elimination pathway.
  • No single metabolite was found to be abundant in plasma relative to the parent drug.
  • An average mass balance of 66% was achieved, showcasing the utility of 19F-NMR for ADME studies.

Conclusions:

  • Elimination of leniolisib occurs mainly through metabolism.
  • 19F-NMR provides a viable method for obtaining extensive elimination and excretion data in early-phase clinical studies without the need for radiolabeled compounds.